Tag Archives: daratumumab

December, 2018

October, 2018

June, 2018

May, 2018

December, 2017

August, 2017

June, 2017

March, 2017

  • 30 March

    Genmab Discontinues Mid-Stage Non-Hodgkin’s Lymphoma Study

    Copenhagen, Denmark; March 30, 2017 — Genmab A/S (Nasdaq Copenhagen: GEN) announced today that its collaboration partner for daratumumab, Janssen Biotech, Inc., has decided not to initiate stage 2 of the Phase II study (CARINA, LYM2001) of daratumumab in three types of relapsed or refractory non-Hodgkin’s lymphoma (NHL).  The study …

November, 2016